
News|Podcasts|March 28, 2025
From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer
Author(s)Alexandra Gerlach, Content Producer
Colorectal cancer cases are on the rise—here is everything you need to know as an oncology pharmacist.
Advertisement
Colorectal cancer (CRC) is the third most common cancer around the world, and although it primarily affects older individuals, diagnoses are on the rise in younger adults. In this episode, we explore the factors driving this increase, the evolving treatment landscape, and the role of emerging therapies in patient care. Our guest, Megan May, PharmD, BCOP, FHOPA, FAPO, clinical oncology pharmacy specialist at Baptist Health, shares insights on the factors driving increased diagnoses, navigating CRC treatment, and the critical role of pharmacists in supporting patient care.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
4
Apnimed Submits NDA for AD109 Following Positive Phase 3 Results in Obstructive Sleep Apnea
5




























































































































